BEVERLY BRISCOE: Open Payments
NPI 1184629206 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 22 payments from 10 companies in 2025. Trend: 2023 $397 · 2024 $476 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novo Nordisk Inc | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Abbott Laboratories | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Kerendia, AIRSUPRA, Ozempic, MOUNJARO, Auvelity, VRAYLAR, CAPLYTA, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
